Skip to main content

AOD-9604: Best Telehealth Providers for Weight Loss Management (2026)

A modified fragment (amino acids 176-191) of human growth hormone designed to stimulate fat metabolism without the growth-promoting effects of full HGH. Studied as a targeted fat-loss peptide.

Sarah Chen
Sarah ChenLead Health Editor
Dr. James Okafor, PharmDReviewed by Dr. James Okafor, PharmDPharmD
Updated January 15, 2025
Fact CheckedClinically Reviewed
Updated January 2025 — may be outdated
Weight LossSubcutaneous injectionPrescription Required

AOD-9604 at a Glance

Category

Weight Loss Management

Administration

Subcutaneous injection

Telehealth Providers

4 compared

Price Range

$150 – $220/mo

Typical Dose

250-500mcg

Frequency

Once daily

Protocol Duration

12-20 weeks

Prescription

Required

Research highlight: AOD-9604 received FDA GRAS (Generally Recognized as Safe) status as a food ingredient in 2014, validating its safety profile as a lipolytic HGH fragment that targets fat loss without activating IGF-1 or insulin-like growth effects.

What is AOD-9604 Used For?

Also known as: Anti-Obesity Drug 9604

  • Fat metabolism
  • Body composition
  • Weight management

How AOD-9604 Works

AOD-9604 is a modified fragment of human growth hormone (amino acids 176–191, the lipolytic domain) with an added tyrosine residue at its N-terminus for stability. It activates the same beta-3 adrenergic receptors as the lipolytic portion of full HGH, stimulating fat cell breakdown (lipolysis) and inhibiting new fat cell formation (lipogenesis). Crucially, it does so without activating the IGF-1 receptor or insulin-like growth effects, making it metabolically safer than full HGH for fat-targeting purposes.

AOD-9604Dosing & Administration

Typical Dose250-500mcg
FrequencyOnce daily
Protocol Duration12-20 weeks
RouteSubcutaneous injection

Dosing information is for educational purposes only. Your prescribing physician will determine the appropriate dose based on your medical history and treatment goals.

What to Expect from AOD-9604

Reduced subcutaneous fat — particularly in abdominal and visceral areas — is the primary goal. Most protocols run 12–20 weeks, with meaningful changes in body composition typically visible at 8–12 weeks. Results are dose-dependent and work best in conjunction with a moderate caloric deficit and resistance training. AOD-9604 is not a replacement for GLP-1 medications in terms of scale of weight loss.

Who Should Consider AOD-9604?

  • Targeted fat loss in already-lean individuals
  • Body recomposition without GH-related side effects
  • Those seeking fat loss without appetite suppression effects
  • Patients who want to avoid IGF-1 elevation from full GH therapy

AOD-9604 Side Effects

  • Generally very well-tolerated in clinical trials
  • Mild injection site redness
  • Headache (uncommon)
  • Nausea (rare)

This is not a complete list of side effects. Always consult your prescribing physician before starting AOD-9604.

4 Telehealth Providers Offering AOD-9604

Sorted by lowest price. All providers require a prescription from a licensed physician.

ProviderPriceDoseRatingConsultationLab Testing
Heally

San Francisco, CA

$150/monthly300mcg/day3.9/5Video TelehealthNot included
Defy Medical

Tampa, FL

$160/monthly300mcg/day4.1/5Video TelehealthIncluded
Evolve Telemed

San Diego, CA

$185/monthly300mcg/day4.0/5Video TelehealthIncluded
TruLife Health

Scottsdale, AZ

$220/monthly300mcg/day4.1/5Video TelehealthIncluded

How to Choose the Best Telehealth Provider for Weight Loss Management

Not all online weight-loss programs are equal. These are the criteria we evaluate when ranking telehealth providers for weight loss medications.

Licensed Medical Supervision

The best providers require a licensed physician or NP to review your health history and approve your prescription — not just an intake algorithm. Asynchronous intake is fine; skipping real medical review is not.

Transparent Per-Dose Pricing

Weight loss programs range from $99 to $500+/month for semaglutide. Look for providers that clearly state the dose included and cost per mg so you can compare programs on equal terms.

Compounding Pharmacy Quality

Compounded medications must come from an FDA-registered 503A or 503B pharmacy. Ask which pharmacy your provider uses and verify its accreditation — sterility and potency standards vary significantly.

Proper Dose Titration

GLP-1 medications should start at a low dose and escalate gradually over weeks. Providers who skip titration to speed results are prioritizing revenue over your safety.

Lab Monitoring

Baseline labs (metabolic panel, HbA1c, lipids) and periodic follow-up are standard of care for GLP-1 therapy. Providers who require or include labs are practicing at a higher standard.

Long-Term Support

Weight management is a long-term commitment. Look for providers with clear refill processes, messaging access to your care team, and supply chain stability beyond the promotional first month.

Frequently Asked Questions About AOD-9604

Is AOD-9604 as effective for weight loss as semaglutide?

No — AOD-9604 produces modest fat loss compared to GLP-1 agonists like semaglutide or tirzepatide. Its mechanism is specifically lipolytic (fat cell breakdown) rather than appetite-suppressing. It is typically chosen for targeted body recomposition in already-lean individuals rather than significant weight reduction in obese patients.

Does AOD-9604 affect blood sugar?

AOD-9604 was specifically designed to separate the lipolytic effects of HGH from its metabolic effects on insulin. Clinical studies show minimal impact on blood glucose, insulin levels, or IGF-1 — making it metabolically safer than full HGH for long-term use in non-diabetic individuals.

Can AOD-9604 be stacked with other peptides?

Yes. Common stacks include AOD-9604 with CJC-1295/Ipamorelin (for muscle growth alongside fat loss) or with semaglutide (for amplified fat-loss effects through complementary mechanisms). Always discuss stacking intentions with your prescribing physician.

Is AOD-9604 FDA-approved?

AOD-9604 received FDA GRAS (Generally Recognized as Safe) status as a food ingredient in 2014 and was studied in Phase 2 obesity trials. However, it did not advance to FDA drug approval. It is currently available through compounding pharmacies under physician prescription.